1.
Breathe (Sheff)
; 20(1): 230126, 2024 Mar.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38482189
RESUMEN
Primary idiopathic hypereosinophilic syndrome is a rare condition that can cause end-organ damage in multiple systems. The advent of targeted monoclonal antibodies, such as mepolizumab, provides a safe and effective steroid-sparing treatment. https://bit.ly/4bgDP1u.